Role of Autophagy in Alzheimer's disease

Jaekwang Kim, Hyejin Yoon, Jungsu Kim

Research output: Contribution to journalArticle

Abstract

Autophagy is a tightly regulated lysosomal degradation/recycling pathway, critical for cellular homeostasis, such as neuronal survival and death. Impaired autophagic function has been reported in several neurodegenerative diseases, such as Parkinson's, Huntington's and Alzheimer's disease (AD). AD is the most common cause of dementia in the elderly and it is characterized by progressive memory loss and cognitive decline along with synaptic dysfunction. Accumulations of amyloid β (Aβ) and tau proteins are two major neuropathological hallmarks of AD. In addition, accumulation of autophagic vacuoles and other autophagic pathology are evident in dystrophic neurites of AD brains. A series of studies has suggested that autophagy is involved in metabolism of Aβ and tau. Moreover, presenilin (PS), a core subunit of γ-secretase complex, has been demonstrated to play an important role in autophagy at the level of lysosomal proteolysis. In spite of several therapeutic approaches through modulation of autophagic pathway, inconsistent results among studies have made it difficult to determine whether autophagy induction will be beneficial or detrimental for AD pathogenesis. Therefore, roles of autophagy in AD need to be further investigated to develop therapeutic strategies in the future.

Original languageEnglish (US)
Pages (from-to)55-66
Number of pages12
JournalCurrent Enzyme Inhibition
Volume9
Issue number1
DOIs
StatePublished - 2013
Externally publishedYes

Fingerprint

Autophagy
Alzheimer Disease
Presenilins
Neurodegenerative diseases
Proteolysis
Serum Amyloid A Protein
tau Proteins
Amyloid Precursor Protein Secretases
Critical Pathways
Huntington Disease
Memory Disorders
Pathology
Neurites
Vacuoles
Metabolism
Neurodegenerative Diseases
Parkinson Disease
Dementia
Recycling
Brain

Keywords

  • Alzheimer's disease
  • Autophagy
  • Beclin
  • mTOR
  • Rapamycin

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Drug Discovery

Cite this

Role of Autophagy in Alzheimer's disease. / Kim, Jaekwang; Yoon, Hyejin; Kim, Jungsu.

In: Current Enzyme Inhibition, Vol. 9, No. 1, 2013, p. 55-66.

Research output: Contribution to journalArticle

Kim, Jaekwang ; Yoon, Hyejin ; Kim, Jungsu. / Role of Autophagy in Alzheimer's disease. In: Current Enzyme Inhibition. 2013 ; Vol. 9, No. 1. pp. 55-66.
@article{9deeaa1f362043ea8329112b5712c3f5,
title = "Role of Autophagy in Alzheimer's disease",
abstract = "Autophagy is a tightly regulated lysosomal degradation/recycling pathway, critical for cellular homeostasis, such as neuronal survival and death. Impaired autophagic function has been reported in several neurodegenerative diseases, such as Parkinson's, Huntington's and Alzheimer's disease (AD). AD is the most common cause of dementia in the elderly and it is characterized by progressive memory loss and cognitive decline along with synaptic dysfunction. Accumulations of amyloid β (Aβ) and tau proteins are two major neuropathological hallmarks of AD. In addition, accumulation of autophagic vacuoles and other autophagic pathology are evident in dystrophic neurites of AD brains. A series of studies has suggested that autophagy is involved in metabolism of Aβ and tau. Moreover, presenilin (PS), a core subunit of γ-secretase complex, has been demonstrated to play an important role in autophagy at the level of lysosomal proteolysis. In spite of several therapeutic approaches through modulation of autophagic pathway, inconsistent results among studies have made it difficult to determine whether autophagy induction will be beneficial or detrimental for AD pathogenesis. Therefore, roles of autophagy in AD need to be further investigated to develop therapeutic strategies in the future.",
keywords = "Alzheimer's disease, Autophagy, Beclin, mTOR, Rapamycin",
author = "Jaekwang Kim and Hyejin Yoon and Jungsu Kim",
year = "2013",
doi = "10.2174/1573408011309010008",
language = "English (US)",
volume = "9",
pages = "55--66",
journal = "Current Enzyme Inhibition",
issn = "1573-4080",
publisher = "Bentham Science Publishers B.V.",
number = "1",

}

TY - JOUR

T1 - Role of Autophagy in Alzheimer's disease

AU - Kim, Jaekwang

AU - Yoon, Hyejin

AU - Kim, Jungsu

PY - 2013

Y1 - 2013

N2 - Autophagy is a tightly regulated lysosomal degradation/recycling pathway, critical for cellular homeostasis, such as neuronal survival and death. Impaired autophagic function has been reported in several neurodegenerative diseases, such as Parkinson's, Huntington's and Alzheimer's disease (AD). AD is the most common cause of dementia in the elderly and it is characterized by progressive memory loss and cognitive decline along with synaptic dysfunction. Accumulations of amyloid β (Aβ) and tau proteins are two major neuropathological hallmarks of AD. In addition, accumulation of autophagic vacuoles and other autophagic pathology are evident in dystrophic neurites of AD brains. A series of studies has suggested that autophagy is involved in metabolism of Aβ and tau. Moreover, presenilin (PS), a core subunit of γ-secretase complex, has been demonstrated to play an important role in autophagy at the level of lysosomal proteolysis. In spite of several therapeutic approaches through modulation of autophagic pathway, inconsistent results among studies have made it difficult to determine whether autophagy induction will be beneficial or detrimental for AD pathogenesis. Therefore, roles of autophagy in AD need to be further investigated to develop therapeutic strategies in the future.

AB - Autophagy is a tightly regulated lysosomal degradation/recycling pathway, critical for cellular homeostasis, such as neuronal survival and death. Impaired autophagic function has been reported in several neurodegenerative diseases, such as Parkinson's, Huntington's and Alzheimer's disease (AD). AD is the most common cause of dementia in the elderly and it is characterized by progressive memory loss and cognitive decline along with synaptic dysfunction. Accumulations of amyloid β (Aβ) and tau proteins are two major neuropathological hallmarks of AD. In addition, accumulation of autophagic vacuoles and other autophagic pathology are evident in dystrophic neurites of AD brains. A series of studies has suggested that autophagy is involved in metabolism of Aβ and tau. Moreover, presenilin (PS), a core subunit of γ-secretase complex, has been demonstrated to play an important role in autophagy at the level of lysosomal proteolysis. In spite of several therapeutic approaches through modulation of autophagic pathway, inconsistent results among studies have made it difficult to determine whether autophagy induction will be beneficial or detrimental for AD pathogenesis. Therefore, roles of autophagy in AD need to be further investigated to develop therapeutic strategies in the future.

KW - Alzheimer's disease

KW - Autophagy

KW - Beclin

KW - mTOR

KW - Rapamycin

UR - http://www.scopus.com/inward/record.url?scp=84877357886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877357886&partnerID=8YFLogxK

U2 - 10.2174/1573408011309010008

DO - 10.2174/1573408011309010008

M3 - Article

AN - SCOPUS:84877357886

VL - 9

SP - 55

EP - 66

JO - Current Enzyme Inhibition

JF - Current Enzyme Inhibition

SN - 1573-4080

IS - 1

ER -